Inanovate develops a longitudinal assay screening technology for the detection and measurement of multiple proteins.
Inanovate has raised $808K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in July 2025.
Inanovate's investors include National Science Foundation, Sanford Frontiers, T. Denny Sanford.
Inanovate is headquartered in Sioux Falls, United States.
Inanovate develops a longitudinal assay screening technology for the detection and measurement of multiple proteins.
Inanovate is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Inanovate — Funding & Investors." VCBacked, July 2, 2025, https://www.vcbacked.co/company/inanovate. Accessed September 30, 2026.
VCBacked. (2025). Inanovate — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/inanovate
{{cite web |title=Inanovate — Funding & Investors |url=https://www.vcbacked.co/company/inanovate |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated